2024 annual financial data
Quince Therapeutics 2024 Operating margin
Quince Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -57,285,000 USD and net income was -56,828,000 USD.
Operating cash flow was -31,904,000 USD.
Get free Quince Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -57,285,000 USD
- Net income
- -56,828,000 USD
- Operating cash flow
- -31,904,000 USD